Company Filing History:
2 out of 1,039 
2 out of 67 
Years Active: 2023-2025
Title: Jan Bornholdt: Innovator in Pharmaceutical Chemistry
Introduction
Jan Bornholdt is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as Janus kinase (JAK) inhibitors. His innovative work has led to the filing of two patents, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Jan Bornholdt's latest patents include processes for preparing 7H-pyrrolo[2,3-d]pyrimidine derivatives. These derivatives are crucial as they function as JAK inhibitors, which are important in treating various diseases. The patents detail methods for synthesizing these compounds and their intermediates, specifically focusing on the preparation of 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile using salts of (3S,4R)-1-benzyl-3-methyl-1,6-diazaspiro[3.4]octane with organic acids.
Career Highlights
Throughout his career, Jan Bornholdt has worked with prominent companies in the pharmaceutical industry, including Japan Tobacco Inc. and Leo Pharma A/S. His experience in these organizations has allowed him to hone his skills and contribute to significant advancements in drug development.
Collaborations
Jan has collaborated with esteemed colleagues such as Hiromu Takiguchi and Akinobu Higashi. These partnerships have further enriched his research and innovation efforts in the field.
Conclusion
Jan Bornholdt is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations in the development of JAK inhibitors. His contributions continue to impact the medical field positively.